Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,168,520 papers from all fields of science
Search
Sign In
Create Free Account
MVE-2
Known as:
MVE 2
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Pyran Copolymer
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
Role of NK cells in immunomodulator-mediated resistance to herpesvirus infection.
S. Kunder
,
L. Wu
,
P. Morahan
Antiviral Research
1993
Corpus ID: 38893177
1989
1989
Anticancer potential of Viva-Natural, a dietary seaweed extract, on Lewis lung carcinoma in comparison with chemical immunomodulators and on cyclosporine-accelerated AKR leukemia.
E. Furusawa
,
S. Furusawa
Oncology
1989
Corpus ID: 46758282
Viva-Natural, extracted from a dietary seaweed, containing a macrophage-activating polysaccharide, has been confirmed to be…
Expand
1988
1988
Maleic vinyl ether anhydride nephropathy: altered glomerular permeability due to an immunomodulating agent.
J. A. Bertolatus
Clinical Immunology and Immunopathology
1988
Corpus ID: 35289568
1988
1988
Effect of pretazettine and viva-natural, a dietary seaweed extract, on spontaneous AKR leukemia in comparison with standard drugs.
Eiichi Furusawa
,
Shinobu Furusawa
Oncology
1988
Corpus ID: 46853788
Antileukemic activity of pretazettine hydrochloride (PTZ: a narcissus alkaloid) and Viva-Natural (a seaweed extract) has been…
Expand
Highly Cited
1985
Highly Cited
1985
Hyporesponsiveness to augmentation of murine natural killer cell activity in different anatomical compartments by multiple injections of various immunomodulators including recombinant interferons and…
J. Talmadge
,
R. Herberman
,
+7 authors
C. Long
Journal of Immunology
1985
Corpus ID: 30714996
Augmentation of natural killer (NK) cell activity has been observed after the single administration of a wide variety of…
Expand
1985
1985
Development of hyporesponsiveness to augmentation of natural killer cell activity after multiple doses of maleic anhydride divinyl ether: association with decreased numbers of large granular…
T. Saito
,
R. Welker
,
H. Fukui
,
R. Herberman
,
M. Chirigos
Cellular Immunology
1985
Corpus ID: 28761369
1984
1984
Immunomodulation and antitumor effects of MVE-2 in mice.
J. Talmadge
,
A. Maluish
,
+4 authors
R. Wiltrout
Journal of Biological Response Modifiers
1984
Corpus ID: 25996940
The biological response modifier maleic anhydride-divinyl ether (MVE-2) can activate natural killer (NK) cells and macrophages…
Expand
1983
1983
Evaluation of the immunological and toxicological properties of MVE-2 in phase I trials.
J. Rinehart
,
D. Young
,
J. Neidhart
Cancer Research
1983
Corpus ID: 9034043
Pyran copolymer enhances resistance to infections and transplantable tumors in mice. It induces interferon, activates macrophages…
Expand
1983
1983
Prostaglandin E synthesis and release by murine macrophages and human monocytes after in vitro treatment with biological response modifiers.
K. Hartung
,
E. Schlick
,
H. Stevenson
,
M. Chirigos
Journal of Immunopharmacology
1983
Corpus ID: 21527246
Prostaglandins of the E series (PGE), produced by mononuclear phagocytes, have many biological activities and are involved in the…
Expand
1982
1982
Inhibition of mammary and urinary bladder carcinogenesis by a retinoid and a maleic anhydride-divinyl ether copolymer (MVE-2).
D. Mccormick
,
P. J. Becci
,
R. Moon
Carcinogenesis
1982
Corpus ID: 31674278
N-(4-hydroxyphenyl)retinamide (4-HPR), a synthetic retinoid, and MVE-2, a maleic anhydride-divinyl ether copolymer, were both…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE